SEC 13F Intelligence

Chicago Capital, LLC / ABMDEUR

Chicago Capital, LLC’s Abiomed Inc Position

Does Chicago Capital, LLC own Abiomed Inc (ABMDEUR)? Not currently — the last reported position was 125.6K shares worth $31M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$31M
Q3 2022
Shares
125.6K
% of Portfolio
+1.79%
Quarters Held
16
position exited

Position History ABMDEUR

Reported value by quarter
Q4 ’18: $22MQ4 ’18Q1 ’19: $19MQ2 ’19: $18MQ2 ’19Q3 ’19: $12MQ4 ’19: $13MQ4 ’19Q1 ’20: $9MQ2 ’20: $11MQ2 ’20Q3 ’20: $23MQ4 ’20: $31MQ4 ’20Q1 ’21: $48MQ2 ’21: $48MQ2 ’21Q3 ’21: $50MQ4 ’21: $55MQ4 ’21Q1 ’22: $51MQ2 ’22: $30MQ2 ’22Q3 ’22: $31Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2022125.6K$31M+1.79%
Q2 2022123.0K$30M+1.68%
Q1 2022153.8K$51M+2.19%
Q4 2021152.0K$55M+2.03%
Q3 2021154.1K$50M+1.90%
Q2 2021154.9K$48M+1.89%
Q1 2021150.2K$48M+2.02%
Q4 202094.5K$31M+1.37%
Q3 202081.7K$23M+1.16%
Q2 202047.2K$11M+0.66%
Q1 202062.3K$9M+0.73%
Q4 201978.4K$13M+0.82%
Q3 201965.0K$12M+0.77%
Q2 201970.7K$18M+1.18%
Q1 201966.6K$19M+1.29%
Q4 201866.7K$22M+1.77%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Chicago Capital, LLC’s full portfolio or all institutional holders of ABMDEUR.